Compare Indoco Remedies with TVS SRICHAKRA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs TVS SRICHAKRA - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES TVS SRICHAKRA INDOCO REMEDIES/
TVS SRICHAKRA
 
P/E (TTM) x 74.0 36.4 203.6% View Chart
P/BV x 4.3 2.0 210.5% View Chart
Dividend Yield % 0.3 1.0 31.4%  

Financials

 INDOCO REMEDIES   TVS SRICHAKRA
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
TVS SRICHAKRA
Mar-20
INDOCO REMEDIES/
TVS SRICHAKRA
5-Yr Chart
Click to enlarge
High Rs3172,270 14.0%   
Low Rs178760 23.4%   
Sales per share (Unadj.) Rs113.12,746.4 4.1%  
Earnings per share (Unadj.) Rs4.5107.4 4.2%  
Cash flow per share (Unadj.) Rs11.8238.2 5.0%  
Dividends per share (Unadj.) Rs1.0020.10 5.0%  
Dividend yield (eoy) %0.41.3 30.4%  
Book value per share (Unadj.) Rs73.2972.5 7.5%  
Shares outstanding (eoy) m92.157.66 1,203.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.20.6 397.2%   
Avg P/E ratio x55.514.1 393.2%  
P/CF ratio (eoy) x21.06.4 329.7%  
Price / Book Value ratio x3.41.6 217.1%  
Dividend payout %22.418.7 119.6%   
Avg Mkt Cap Rs m22,83011,605 196.7%   
No. of employees `0005.52.8 194.8%   
Total wages/salary Rs m2,2092,936 75.2%   
Avg. sales/employee Rs Th1,910.17,513.4 25.4%   
Avg. wages/employee Rs Th405.01,048.5 38.6%   
Avg. net profit/employee Rs Th75.5293.8 25.7%   
INCOME DATA
Net Sales Rs m10,41921,037 49.5%  
Other income Rs m47102 46.0%   
Total revenues Rs m10,46621,139 49.5%   
Gross profit Rs m1,3492,153 62.7%  
Depreciation Rs m6771,002 67.6%   
Interest Rs m235379 62.1%   
Profit before tax Rs m484874 55.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7252 140.3%   
Profit after tax Rs m412823 50.0%  
Gross profit margin %12.910.2 126.5%  
Effective tax rate %15.05.9 253.5%   
Net profit margin %4.03.9 101.0%  
BALANCE SHEET DATA
Current assets Rs m5,3737,299 73.6%   
Current liabilities Rs m4,1576,146 67.6%   
Net working cap to sales %11.75.5 212.9%  
Current ratio x1.31.2 108.8%  
Inventory Days Days6873 92.8%  
Debtors Days Days7336 202.3%  
Net fixed assets Rs m6,2447,199 86.7%   
Share capital Rs m18477 240.6%   
"Free" reserves Rs m6,5667,373 89.1%   
Net worth Rs m6,7507,449 90.6%   
Long term debt Rs m1,2331,292 95.4%   
Total assets Rs m12,36316,162 76.5%  
Interest coverage x3.13.3 92.5%   
Debt to equity ratio x0.20.2 105.3%  
Sales to assets ratio x0.81.3 64.7%   
Return on assets %5.27.4 70.4%  
Return on equity %6.111.0 55.2%  
Return on capital %9.014.3 62.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,7622,031 185.3%   
Fx outflow Rs m1,1432,593 44.1%   
Net fx Rs m2,619-563 -465.5%   
CASH FLOW
From Operations Rs m1,2272,977 41.2%  
From Investments Rs m-1,360-1,342 101.3%  
From Financial Activity Rs m-388-1,686 23.0%  
Net Cashflow Rs m-521-51 1,030.9%  

Share Holding

Indian Promoters % 59.2 45.4 130.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 2.6 480.8%  
FIIs % 6.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 52.1 43.0%  
Shareholders   12,805 23,740 53.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   WONDERLA HOLIDAYS  REDINGTON  CREST VENTURES  TIMKEN INDIA  NALWA SONS INV  



Today's Market

Sensex Trades Marginally Lower; Dow Futures Up by 90 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 34 points, up 0.1% at 48,844 levels.

Related Views on News

TVS SRICHAKRA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of TVS SRICHAKRA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of TVS SRICHAKRA. Also includes updates on the valuation of TVS SRICHAKRA.

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9% (Quarterly Result Update)

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

TVS SRICHAKRA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 19, 2019 | Updated on Aug 19, 2019

Here's an analysis of the annual report of TVS SRICHAKRA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TVS SRICHAKRA. Also includes updates on the valuation of TVS SRICHAKRA.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021(Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021(Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Jan 25, 2021 01:26 PM

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 8-QTR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS